SCHEMBL5801802

SCHEMBL5801802

[CH2]CC(O)(O)CC(O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7522629 0.75 LMNA (0.40)
SCHEMBL9079306 0.73
SCHEMBL5165478 0.71
SCHEMBL10030769 0.65
SCHEMBL8647482 0.65
SCHEMBL7189557 0.62
SCHEMBL1904383 0.62
SCHEMBL270883 0.61
SCHEMBL8831187 0.60
SCHEMBL16592163 0.60 TSHR (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150313823-A1 CATIONIC PYRITHIONE DISPERSION ARCH PERSONAL CARE PRODUCTS, LP 2015-11-05 US claimed
EP-2934138-A1 CATIONIC PYRITHIONE DISPERSION ARCH PERSONAL CARE PRODUCTS, LP (US) 2015-10-28 EP claimed
WO-2014100709-A1 CATIONIC PYRITHIONE DISPERSION ARCH PERSONAL CARE PRODUCTS, LP (US) 2014-06-26 WO claimed
EP-1658069-A1 HETEROCYCLIC AMIDE DERIVATIVES WHICH POSSESS GLYCOGEN PHOSPHORYLASE INHIBITORY ACTIVITY Astrazeneca AB (SE) 2006-05-24 EP disclosed
WO-2005013981-A1 HETEROCYCLIC AMIDE DERIVATIVES WHICH POSSESS GLYCOGEN PHOSPHORYLASE INHIBITORY ACTIVITY ASTRAZENECA AB (SE) 2005-02-17 WO disclosed
WO-1998048768-A9 COMPOSITIONS FOR COSMETIC APPLICATIONS MEDLOGIC GLOBAL CORP (US) 1999-03-25 WO disclosed
US-5641480-A ENHANCED STABILITY AND/OR VISCOSITY, CLARITY LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) 1997-06-24 US disclosed